Medicaroid wins CE mark for surgical robot
July 7, 2026
Japanese medtech company Medicaroid announced today that it received CE mark approval for its Hinotori surgical robot system.
Japanese medtech company Medicaroid announced today that it received CE mark approval for its Hinotori surgical robot system.
It’s a fact of life that the electrical activity of neurons will vary during the same task, even when the ultimate outcome is the same.
A new “tumor-on-a-chip” model is giving scientists a live look at how pancreatic cancer can recruit the body’s own immune cells to help tumors survive.
What happens to the human body in space may help scientists create new anti-aging therapies.
Parkinson’s disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide.
A University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication.
WILMINGTON, Del., July 6, 2026 /PRNewswire/ — Reprotech today announced that the TMRW Vault® has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, supporting commercialization in the European Union and other international markets that recognize the CE mark.
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
Movmedix announced today that it received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant platform.
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions.